Skip to content
How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing episode artwork

Jul 13, 2023 21 min

How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing

from Rx for Biotech Hosted by Podcast Host Christopher Leidli

In this podcast episode, Tomasz George, Chief Scientific Officer at Virax Biolabs, shares how the company's ViraxImmune™ technology platform will empower patients to take control of their health and make informed decisions on how to respond to current and future viral threats. The company hopes their ViraxImmune™ platform will shift the way individuals are able to manage aspects of their immune health.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing

0:00 21:14

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Rx for Biotech?

This episode is 21 minutes long.

When was this Rx for Biotech episode published?

This episode was published on July 13, 2023.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.